Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
Get Insiders for : 
Adaptimmune Therapeutics PLC (ADAP)  
$0.25 0.00 (1.16%) as of 4:30 Fri 6/27


Download
   
Exchange: N/A
Security Type: Common
Shares Out: 154,660,000
Market Cap: 37.89(M)
Last Volume: 0 Avg Vol: 0
52 Week Range: $0.197 - $1.39
Level I Sector: N/A
Level II Sector: N/A
Level III Sector: N/A

Member Indexes:
   

Rankings:
     
Insider 3 Months    :   -
Insider 6 Months    :   -
Insider 3/6 Months :   -
Guru Rank Number :  -
Guru Rank Value     :  -
Guru Occurances    :  -

 

            6 Months   1 Year   2 Year  
 
Company Profile   Adaptimmune Therapeutics is a biopharmaceutical company focused on developing T-cell therapies for solid tumors. Co.'s proprietary SPEAR (Specific Peptide Enhanced Affinity Receptor) T-cell platform enables it to identify cancer targets, find and genetically engineer T-cell receptors against those targets, and produce therapeutic candidates (SPEAR T-cells) for administration to patients. Co. has clinical trials on its ADP-A2M4, ADP-A2M4CD8, each targeting the MAGE-A4 antigen, and ADP-A2AFP SPEAR T-cells targeting the alpha fetoprotein (AFP) cancer antigen in solid tumor types including non-small cell lung cancer, head and neck cancer, ovarian, urothelial, melanoma, and hepatocellular.

 
 
Summary  (Direct Transactions Only) 3 Months 6 Months 12 Months 24 Months
Total Shares Bought 0 0 0 0
Total Buy Value $0 $0 $0 $0
Total People Bought 0 0 0 0
Total Buy Transactions 0 0 0 0
Total Shares Sold 0 181,192 181,192 422,320
Total Sell Value $0 $105,250 $105,250 $298,700
Total People Sold 0 5 5 6
Total Sell Transactions 0 13 13 32
End Date 2025-03-30 2024-12-27 2024-06-28 2023-06-29

   
Records found: 248
  Page 1 of 10  
Filer's Name Relation Title Off-Dir-10% Tran. Date Form Action Price Mkt Value D/I Shares Holdings
Rank

  
3m +/-  
Form
   Norry Elliot Chief Medical Officer   •       –      –    2025-01-17 4 S $0.58 $3,243 D/D (5,584) 7,510 53%     
   Rawcliffe Adrian Chief Executive Officer   •       •      –    2025-01-17 4 S $0.58 $17,773 D/D (30,601) 44,327 53%     
   Lunger John Chief Patient Supply Officer   •       –      –    2025-01-17 4 S $0.58 $3,243 D/D (5,584) 7,510 53%     
   Bertrand William C Jr Chief Operating Officer   •       –      –    2025-01-17 4 S $0.58 $3,243 D/D (5,584) 7,510 53%     
   Norry Elliot Chief Medical Officer   •       –      –    2025-01-15 4 S $0.57 $5,635 D/D (9,803) 13,756 54%     
   Bertrand William C Jr Chief Operating Officer   •       –      –    2025-01-15 4 S $0.57 $5,635 D/D (9,803) 13,756 54%     
   Rawcliffe Adrian Chief Executive Officer   •       •      –    2025-01-15 4 S $0.57 $16,724 D/D (29,096) 41,582 54%     
   Piccina Cintia Chief Commercial Officer   •       –      –    2025-01-15 4 S $0.57 $7,467 D/D (12,991) 18,421 54%     
   Lunger John Chief Patient Supply Officer   •       –      –    2025-01-15 4 S $0.57 $5,635 D/D (9,803) 13,756 54%     
   Norry Elliot Chief Medical Officer   •       –      –    2025-01-13 4 S $0.59 $7,285 D/D (12,392) 11,516 54%     
   Bertrand William C Jr Chief Operating Officer   •       –      –    2025-01-13 4 S $0.59 $5,726 D/D (9,739) 7,623 54%     
   Rawcliffe Adrian Chief Executive Officer   •       •      –    2025-01-13 4 S $0.59 $17,915 D/D (30,473) 25,711 54%     
   Lunger John Chief Patient Supply Officer   •       –      –    2025-01-13 4 S $0.59 $5,726 D/D (9,739) 7,623 54%     
   Piccina Cintia Chief Commercial Officer   •       –      –    2024-06-18 4 S $0.93 $22,814 D/D (24,531) 38,293 16%     
   Ecor1 Capital, Llc 10% Owner   –       –       •   2024-03-08 3 IO $0.00 $0 I/I 0 164,424,420 -33%     
   Norry Elliot Chief Medical Officer   •       –      –    2024-01-17 4 S $0.67 $12,300 D/D (18,276) 19,257 -43%     
   Lunger John Chief Patient Supply Officer   •       –      –    2024-01-17 4 S $0.67 $12,191 D/D (18,114) 19,015 -43%     
   Bertrand William C Jr Chief Operating Officer   •       –      –    2024-01-17 4 S $0.67 $12,725 D/D (18,908) 20,201 -43%     
   Rawcliffe Adrian Chief Executive Officer   •       •      –    2024-01-17 4 S $0.67 $20,244 D/D (30,080) 44,848 -43%     
   Norry Elliot Chief Medical Officer   •       –      –    2024-01-16 4 S $0.79 $1,807 D/D (2,287) 3,363 -48%     
   Lunger John Chief Patient Supply Officer   •       –      –    2024-01-16 4 S $0.79 $3,698 D/D (4,681) 7,023 -48%     
   Bertrand William C Jr Chief Operating Officer   •       –      –    2024-01-16 4 S $0.79 $3,698 D/D (4,681) 7,023 -48%     
   Rawcliffe Adrian Chief Executive Officer   •       •      –    2024-01-16 4 S $0.79 $7,350 D/D (9,304) 14,104 -48%     
   Lunger John Chief Patient Supply Officer   •       –      –    2024-01-12 4 S $0.85 $4,458 D/D (5,220) 7,874 -23%     
   Bertrand William C Jr Chief Operating Officer   •       –      –    2024-01-12 4 S $0.85 $4,458 D/D (5,220) 7,874 -23%     
  248 Records found
  1  2  3  4  5  6  7  8  9  Next   
  Page 1 of 10
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
  OE - Options Exercised A - Acquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2025 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us